A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory.

@article{King2008ARF,
  title={A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory.},
  author={Madeleine V. King and Charles Alexander Marsden and Kevin C. F. Fone},
  journal={Trends in pharmacological sciences},
  year={2008},
  volume={29 9},
  pages={482-92}
}
The serotonergic system is implicated in the neurobiological control of learning and memory, both in healthy individuals and pathological disorders, although the underlying mechanisms remain elusive. After the cloning and characterization of serotonin, or 5-hydroxytryptamine (5-HT), receptors and the resultant development of selective agonist and antagonist compounds and transgenic receptor-knockout mice, our understanding of the role of various serotonin receptors in learning and memory has… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
This information raises the possibility that such compounds could be developed as adjunct therapeutics with existing treatments to improve learning and memory deficits , which are core symptoms of Alzheimer 's disease , schizophrenia and depression .
This information raises the possibility that such compounds could be developed as adjunct therapeutics with existing treatments to improve learning and memory deficits , which are core symptoms of Alzheimer 's disease , schizophrenia and depression .
This information raises the possibility that such compounds could be developed as adjunct therapeutics with existing treatments to improve learning and memory deficits , which are core symptoms of Alzheimer 's disease , schizophrenia and depression .
This information raises the possibility that such compounds could be developed as adjunct therapeutics with existing treatments to improve learning and memory deficits , which are core symptoms of Alzheimer 's disease , schizophrenia and depression .
This information raises the possibility that such compounds could be developed as adjunct therapeutics with existing treatments to improve learning and memory deficits , which are core symptoms of Alzheimer 's disease , schizophrenia and depression .
This information raises the possibility that such compounds could be developed as adjunct therapeutics with existing treatments to improve learning and memory deficits , which are core symptoms of Alzheimer 's disease , schizophrenia and depression .
All Topics